Precipio outlines 2027 exit run-rate targets exceeding $40M, led by products above $10M
At a glance
- $PRPO today−4.51%last $19.06
- Vs industry peers−3.94 pts6-peer median −0.57% · far behind
- Since Nov 10−19.7%from the first trade after the story
- 52-week range7.1% above low$17.79 – $33.63
- Last reported loss$8Kquarter to Sep 30, 2026 · 10-Q
- In the headline$40 millionAmount
Nothing reported about precipio across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: A single blockbuster product can turn a drugmaker's fortunes — especially when it's already outperforming expectations.
- How the stock is trading: $PRPO -4.51% in the latest session.
- Timing: It was published overnight, so the session change shown belongs to a day that had already closed. Market holidays are not detected.
Where the stock stands
Precipio ($PRPO) slid 4.51% to $19.06 in the latest session. Over the past month it is down 12.9%. It now sits 43% under the 52-week high of $33.63 and 7.1% above the year's low of $17.79, close to the bottom of its range. Its 52-week range spans 89% from low to high, so weekly moves of several percent are normal.
What the filings say
In its latest report (10-Q, filed Nov 10, 2026), $PRPO lost $8K over the quarter to Sep 30, 2026 on revenue of $7.4M (+5.2% QoQ). Operations brought in $1.3M of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was $1.1M. It carried $347K of debt against $3.6M of cash on Sep 30, 2026 — net cash of $3.2M. The company filed an 8-K — the form for material events — on Nov 10, the same day as this story; it is $PRPO's own account and the first thing to read. Figures are as filed with the SEC; the $PRPO page has the full statements.
How much coverage it is getting
Wook has no other story on Precipio from the last 30 days, so there is no recent run to compare this one with.
The bigger picture
In healthcare, timing is everything — from trial results to regulatory decisions. One event can shift a company's trajectory, while broader policy shifts can reshape the entire sector. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
The $PRPO page has the full chart, filings, and valuation model. Comparing coverage from different outlets helps confirm the story or spot repetition. Wook AI can also crunch the numbers — tracking how far $PRPO has come from its peak or how this week's news stacks up.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 11, 2026. $PRPO has moved -19.75% ($23.75 to $19.06). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
